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The study of the antimicrobial activity of ethylene-N,N’-
bis(spiroindole-3,3’-pyrrolo[3,4-c]pyrrole-2a’,5a’-dihydro-
2,2’,6’(1H,1’H,5’H)-trione) derivatives
Aim. To find compounds with the antimicrobial activity in the series of N,N’-bis(spiroindole-3,3’-pyrrolo[3,4-c]
pyrrol-2а’,5а’-dihydro-2,2’,6’(1H,1’H,5’H)-trione) derivatives.
Materials and methods. The antimicrobial activity was studied by the agar diffusion method.
Results and discussion. The antimicrobial screening data revealed the pronounced biological activity of ethylene-
N,N’-bis(spiroindole-3,3’-pyrrolo[3,4-с]pyrrol-2а’,5а’-dihydro-2,2’,6’(1H,1’H,5’H)-trione) derivatives against gramnegative 
(Proteus vulgaris, Escherichiа coli, Pseudomonas aeruginosa) and grampositive (Staphylococcus aureus, Bacillus 
subtilis) bacteria and as well as against Candida albicans fungi.
Conclusions. The antibacterial activity of ethylene-N,N’-bis(spiroindole-3,3’-pyrrolo[3,4-с]pyrrol-2а’,5а’-dihydro-
2,2’,6’(1H,1’H,5’H)-trione) derivatives has been studied. The compounds with a significant level of the antimicrobial 
activity against gramnegative bacteria (Proteus vulgaris, Escherichiа coli, Pseudomonas aeruginosa), grampositive 
bacteria (Staphylococcus aureus, Bacillus subtilis), as well as against fungi (Candida albicans) have been found. 
According to the data of the microbiological screening the most active compounds appeared to be ethylene-N,N’-
bis(spiroindole-3,3’-pyrrolo[3,4-с]pyrrol-2а’,5а’-dihydro-2,2’,6’(1H,1’H,5’H)-trione) 1 and ethylene-N,N’-bis(spiroindole-
3,3’-pyrrolo[3,4-с]pyrrol-5′-methyl-2а’,5а’-dihydro-2,2’,6’(1H,1’H,5’H)-trione) 2.
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Дослідження антимікробної активності похідних етилен-N,N’-біс(спіроіндол-3,3’-
піроло[3,4-с]пірол-2а’,5а’-дигідро-2,2’,6’(1H,1’H,5’H)-триону)
Мета роботи – виявлення сполук з антимікробною активністю в ряду похідних етилен-N,N’-біс(спіроіндол-
3,3’-піроло[3,4-с]пірол-2а’,5а’-дигідро-2,2’,6’(1H,1’H,5’H)-триону). 
Матеріали та методи. Дослідження антимікробної активності методом дифузії в агар у модифікації колодязів.
Результати та їх обговорення. Дані мікробіологічного скринінгу показали виражену біологічну дію похід-
них етилен-N,N’-біс(спіроіндол-3,3’-піроло[3,4-с]пірол-2а’,5а’-дигідро-2,2’,6’(1H,1’H,5’H)-триону) відносно грам-
негативних Proteus vulgaris, Escherichiа coli, Pseudomonas aeruginosa і грампозитивних бактерій Staphylococcus 
aureus, Bacillus subtilis та грибів Candida albicans. 
Висновки. Досліджено антибактеріальну активність похідних етилен-N,N’-біс(спіроіндол-3,3’-піроло[3,4-с]
пірол-2а’,5а’-дигідро-2,2’,6’(1H,1’H,5’H)-триону). Виявлені сполуки зі значним рівнем біологічної активності від-
носно грамнегативних бактерій: Proteus vulgaris, Escherichiа coli, Pseudomonas aeruginosa, грампозитивних 
бактерій: Staphylococcus aureus, Bacillus subtilis та грибів Candida albicans. За даними мікробіологічного скри-
нінгу найбільш активними виявились сполуки: етилен-N,N’-біс(спіроіндол-3,3’-піроло[3,4-с]пірол-2а’,5а’-дигідро-
2,2’,6’(1H,1’H,5’H)-трион) 1 та етилен-N,N’-біс(спіроіндол-3,3’-піроло[3,4-с]пірол-5’-метил-2а’,5а’-дигідро-2,2’,6’ 
(1H,1’H,5’H)-трион) 2.
Ключові слова: біс-спіро-2-оксіндол; подвійні ліки; бактерії; антибактеріальні засоби
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Исследование антимикробной активности производных этилен-N,N’-
бис(спироиндол-3,3’-пирроло[3,4-с]пиррол-2а’,5а’-дигидро-2,2’,6’(1H,1’H,5’H)-триона)
Цель работы – обнаружение соединений с антимикробной активностью в ряду производных этилен-N,N’-
бис(спироиндол-3,3’-пирроло[3,4-с]пиррол-2а’,5а’-дигидро-2,2’,6’(1H,1’H,5’H)-триона).
Материалы и методы. Исследование антимикробной активности методом диффузии в агар в модифика-
ции колодцев.
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Результаты и их обсуждение. Данные микробиологического скрининга показали выраженное биологи-
ческое действие синтезированных соединений относительно грамотрицательных Proteus vulgaris, Escherichiа 
coli, Pseudomonas aeruginosa, грамположительных бактерий Staphylococcus aureus, Bacillus subtilis и грибов 
Candida albicans.
Выводы. Исследована антибактериальная активность производных этилен-N,N’-бис(спироиндол-3,3’-пирроло 
[3,4-с]пиррол-2а’,5а’-дигидро-2,2’,6’(1H, 1’H,5’H)-триона). Обнаружены соединения со значительным уровнем 
биологической активности относительно грамотрицательных бактерий: Proteus vulgaris, Escherichiа coli, Pseudomonas 
eruginosa, грамположительных бактерий: Staphylococcus aureus, Bacillus subtilis и грибов Candida albicans. 
По данным микробиологического скрининга наиболее активными оказались соединения: этилен-N,N’-бис 
(спироиндол-3,3’-пирроло[3,4-с]пиррол-2а’,5а’-дигидро-2,2’,6’(1H,1’H,5’H)-трион) 1 и этилен-N,N’-бис(спироиндол- 
3,3’-пирроло[3,4-с]пиррол-5’-метил-2а’,5а’-дигидро-2,2’,6’(1H,1’H,5’H)-трион) 2.
Ключевые слова: бис-спиро-2-оксиндол; двойные лекарства; бактерии; антибактериальные средства
According to the data published by the WHO, infec-
tious diseases are the 4th ranked cause of mortality in 
the world. More than 17 million people die of an infec-
tious pathology per year [1]. Difficulties of treatment 
and prevention of these diseases are caused by a variety 
of biological forms of causative agents, permanent arising 
of resistant forms of strains and by emergence of new 
kinds of dangerous pathogens. Therefore, creation of new 
antimicrobial drugs is topical issue of medicinal chemistry.
Recently, in synthetic chemistry much attention is 
paid to spirocombined pyrrolooxindoles, which core is 
the basis of natural alkaloids that exhibit a pronounced 
antibacterial activity [2]. The spatial arrangement of the 
pyrrolooxindole core is the probable reason for its strong 
binding with tridimensional sites of biotargets in a micro-
bial cell [3]. Since most of the known inhibitors of micro-
bial enzymes have a plane or almost plane structure, they 
can not bind with specific fragments into biotargets above 
and below of the molecule plane. This is the cause of 
their low selectivity [4].
On the other hand, such chemical classes as bis-spiro- 
oxindoles, dispirioxindoles and bis-spiroindoles are of 
great interest for creation of double drugs. It has been 
proven that development of biologically active compounds 
comprising two similar pharmacophors bound by the co-
valent bond leads to a significant increase of the biological 
activity [5]. Thus, the bis-spirooxindole core is the basis 
of such alkaloids as geleganidine C, geleganimine B, bi-
pleiophylline possessing the antibacterial activity (Fig. 1) [6-9]. 
Thus, the search of new antimicrobial agents among 
derivatives of bis-spiro-2-oxindole-3,3′-pyrrole is the pro- 
mising way to create new effective drugs.
Earlier it was found [10] that [3+2]-cycloaddition 
of two-fold excess of azomethine ylides generated in situ 
from isatines and aminoacids to 1,6-bismaleinimidohe- 
xane led to formation of hexamethylene-N,N’-bis-spiro- 
indole-3,3’-pyrrolo[3,4-с]pyrrol-2а’,5а’-dihydro-2,2’,6’ 
(1H,3’H,5’H)-triones. These compounds showed a signifi-
cant antibacterial activity. In continuation of the studies 
devoted to the search of new antibacterial agents we syn-
thesized the series of ethylene-N,N’-bis(spiroindole-3,3’- 
pyrrolo[3,4-с]pyrrole-2а’,5а’-dihydro-2,2’,6’(1H,1’H, 
5’H)-trione) derivatives [11] (Fig. 2).
N,N’-Di(3-carboxypropenoyl)-1,2-ethylendiamine 
was used as a dipolarophile for preparing compounds 
cited above. This reagent is similar to the antibacterial 
drug Ethambutol ((2S,2’S)-2,2’-(Ethane-1,2-diyldiimi-
no)dibutan-1-ol) by its chemical structure [12]. The aim 
of the current research was to investigate the antibac-
terial properties of the substances synthesized against 
standard types of microorganisms (gram-positive and 
gram-negative).
Materials and methods
The microbiological studies were performed at the 
premises of the State Institution “Institute of Microbiology 
and Immunology named after I. I. Mechnikov of the 
National Academy of Medical Sciences of Ukraine”.
According to the WHO recommendations [13, 14] 
and recommendations of the Ministry of Health of Ukraine 
[15, 16] Staphylococcus aureus – АТСС 25923, Esche- 
richiа coli – АТСС 25922, Pseudomonas aeruginosa 
АТСС – 27853, Bacillus subtilis АТСС – 6633, Proteus 
vulgaris – ATCC 4636 and Candida albicans – АТСС 
885/653 were used as test-strains in our study.
In vitro evaluation of the antimicrobial activity of the 
compounds synthesized was performed using the agar 
diffusion method.
The suspension of microorganisms was prepared on 
a Densi-La-Meter device (PLIVA-Lachema, Czech Re-
public; with the wavelength of 540 nm) according to the 
instruction No. 163-2006 “Standardization of preparation 
of microbial suspensions” [17-19]. Synchronization of cul-
tures was carried out at the temperature of 4 °С. The micro-
bial load was 107 microbial cells per 1 ml of the medium 
and was determined according to McFarland standard. For 
experiments the 18-24-hour culture of microorganisms 
was used. For the research Muller- Hinton agar and Sabu-
ro-dextrose agar (for C. albicans) were used. 
The sample of the compound studied (1 mg) was 
dissolved in 1 mL of DMSO. 0.3 mL of the solution was 
taken and introduced into wells on Petri dish with micro-
bial strains. Petri dishes were dried for 30-40 min at room 
temperature and kept in a thermostat for 18 to 24 h at 37 °C.
The level of the antimicrobial activity was determi- 
ned as diameters of inhibition growth zones around the 
well with the compound studied. The results obtained were 
compared with the strain growth in the control test.
Results and discussion
The results of the antimicrobial activity of ethylene- 
N,N’-bis(spiroindole-3,3’-pyrrolo[3,4-с]pyrrole-2а’,5а’- 
dihydro-2,2’,6’(1H,1’H,5’H)-trione) derivatives 1-10 are 
given in Table.
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The hexamethylene-N,N’-bis(spiroindole-3,3’-pyrrolo 
[3,4-с]pyrrole-2а’,5а’-dihydro-2,2’,6’(1H,1’H,5’H)-trione) 
derivatives previously studied showed a high antibacte-
rial activity against Staphylococcus aureus and a mode- 
rate fungicidal activity against Candida albicans [10]. 
Ethylene-N,N’-bis(spiroindole-3,3’-pyrrolo[3,4-с]pyr- 
role-2а’,5а’-dihydro-2,2’,6’(1H,1’H,5’H)-trione) deriva-
tives 1-10 showed a wider range of the antimicrobial 
activity. All microorganisms were sensitive to com-
pounds 1-10. Thus, the growth inhibition zones for all 
compounds synthesized against Proteus vulgaris were 
on average 1 mm larger compared to the reference drug 
(Synthomycine). The growth inhibition zones against 
Escherichia coli were on average 2 mm, while against 
Pseudomonas aeruginosa was 5 mm larger for the com-
pounds studied compared to the reference drug. In the 
case of gram-positive bacteria compounds 1-10 also sho- 
wed a high activity (the growth inhibition zones against 
Staphylococcus aureus, Bacillus subtilis were on average 
3 mm larger compared to the reference drug). But the 
highest level of activity was found in relation to Can-
dida albicans fungi. The growth inhibition zones against 
fungi were on average 7 mm larger compared to the re- 
ference drug (Metronidazole). Thus, in general, the com-
pounds synthesized were even more active than the refe- 
rence drugs Syntomycin and Metronidazole.
Fig. 1. Alkaloids containing the bis-spirooxindole core
Fig. 2. The general formula of ethylene-N,N’-bis(spiroindole-3,3’-
pyrrolo[3,4-с]pyrrole-2а’,5а’-dihydro-2,2’,6’(1H,1’H,5’H)-trione) 
derivatives
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CONCLUSIONS 
The antibacterial activity of ethylene-N,N’-bis(spiro- 
indole-3,3’-pyrrolo[3,4-с]pyrrol-2а’,5а’-dihydro-
2,2’,6’(1H,1’H,5’H)-trione) derivatives has been stu- 
died. The compounds with a significant level of the 
antimicrobial activity against gramnegative bacteria 
(Proteus vulgaris, Escherichiа coli, Pseudomonas aeru- 
ginosa), grampositive bacteria (Staphylococcus aureus, 
Bacillus subtilis), as well as against fungi (Candida 
albicans) have been found. According to the data of the 
microbiological screening the most active compounds 
appeared to be ethylene-N,N’-bis(spiroindole-3,3’-pyr- 
rolo[3,4-с]pyrrol-2а’,5а’-dihydro-2,2’,6’(1H,1’H, 
5’H)-trione) 1 and ethylene-N,N’-bis(spiroindole-3,3’- 
pyrrolo[3,4-с]pyrrol-5′-methyl-2а’,5а’-dihydro-2,2’,6’ 
(1H,1’H,5’H)-trione) 2.
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The antimicrobial activity of ethylene-N,N’-bis(spiroindole-3,3’-pyrrolo[3,4-с]pyrrole-2а’,5а’-dihydro-
2,2’,6’(1H,1’H,5’H)-trione) derivatives 1-10
Compound
Diameter of the growth inhibition zones*, mm
Grampositive bacteria Gramnegative bacteria Fungi
S. aureus B. subtilis E. coli P. aeruginosa P. vulgaris C. albicans
1 (R = R1 = H) 16 20 20 22 19 23
2 (R = CH3; R1 = H) 16 20 20 21 19 23
3 (R = i-Pr; R1 = H) 19 21 19 22 18 22
4 (R = i-Bu; R1 = H) 20 20 18 22 17 23
5 (R = Ph; R1 = H) 16 21 17 22 16 22
6 (R = i-Pr; R1 = H) 19 19 20 22 18 23
7 (R = Bn; R1 = H) 16 20 18 22 17 22
8 (R = 4-OH-C6H4- -CH2-; R1 = H) 15 20 18 22 17 22
9 (R = H; R1 = CH3) 17 20 19 21 18 23
10 (R = R1 = CH2-CH2--CH2) 15 21 19 22 18 22
Control growth growth growth growth growth growth
Synthomycine 14 17 17 17 17 0
Metronidazole 14 16 14 0 0 14
Note: * – The data presented are the mean values for three experiments relative to each microorganism culture.
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